Kath is Interim Deputy Director Health & Care at Innovate UK and leads a team delivering programmes in precision medicine, drug discovery, digital health and disease prevention & wellbeing. Innovate UK is the UK’s innovation agency, a non-departmental public body which is the prime channel through which the Government incentivises innovation in business.
Kath has over 15 years’ experience in commercial business development and marketing, and life sciences research, spanning multiple disease areas and technologies. Most recently, Kath was Business Development Director at Epistem Plc, where she established the business development platform for their service business in the USA, leading a team to initiate new projects to develop therapeutics and companion biomarkers for regenerative medicine, oncology and inflammation.
Kath holds a PhD in Pharmacology and BSc in Pharmacology & Physiology from the University of Manchester.